The Enterprise Value as of December 2024 (TTM) for Anavex Life Sciences Corp. (AVXL) is 809.26M

According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 809.26M. This represents a change of 119.43% compared to the average of 368.81M of the last 4 quarters.

Anavex Life Sciences Corp. (AVXL) Historical Enterprise Value (quarterly & annually)

How has AVXL Enterprise Value performed in the past?

The mean historical Enterprise Value of Anavex Life Sciences Corp. over the last ten years is 326.88M. The current 809.26M Enterprise Value has changed 24.66% with respect to the historical average. Over the past ten years (40 quarters), AVXL's Enterprise Value was at its highest in in the June 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the March 2015 quarter at 6.01M.

Anavex Life Sciences Corp. (AVXL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anavex Life Sciences Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anavex Life Sciences Corp. (AVXL) Average Enterprise Value

How has AVXL Enterprise Value performed in the past?

The current Enterprise Value of Anavex Life Sciences Corp. (AVXL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Anavex Life Sciences Corp. (AVXL) Enterprise Value vs. Peers

How is AVXL’s Enterprise Value compared to its peers?

Anavex Life Sciences Corp.’s Enterprise Value is greater than Cassava Sciences, Inc. (-33031695.00), greater than INmune Bio, Inc. (70.25M), greater than BioVie Inc. (20.30M), greater than Cognition Therapeutics, Inc. (4.08M), greater than Annovis Bio, Inc. (48.90M), less than Iovance Biotherapeutics, Inc. (2.19B), less than Axsome Therapeutics, Inc. (4.08B), less than Novavax, Inc. (1.04B), less than Exelixis, Inc. (9.50B), less than TG Therapeutics, Inc. (5.08B), less than Viking Therapeutics, Inc. (4.67B), less than Madrigal Pharmaceuticals, Inc. (6.67B), greater than BioXcel Therapeutics, Inc. (81.77M), greater than Reviva Pharmaceuticals Holdings, Inc. (70.91M), greater than Eyenovia, Inc. (15.24M), greater than TransCode Therapeutics, Inc. (769.13K), greater than Kodiak Sciences Inc. (362.34M),

Build a custom stock screener for Anavex Life Sciences Corp. (AVXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anavex Life Sciences Corp. (AVXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.